News
Dear readers/followers, You may recall some previous coverage of a Belgian company (currently the only Belgian company I own), with the name of Etablissementen...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow Author and entrepreneur. My articles typically cover macroeconomic trends, portfolio strategy, value investing, and behavioral finance. I like...
News
This article was written by Follow Dhierin-Perkash Bechai is an aerospace, defense and airline analyst. Dhierin runs the investing group The Aerospace Forum, whose...
News
This article was written by Follow Yiannis Zourmpanos, founder of Yiazou IQ, an AI-driven stock research platform providing all-in-one stock reports. Experience: Previously worked...
News
The numbers: Mortgage rates rose for the third week in a row to their highest level since October 2022, as the U.S. economy shows...
News
“A shoe is just a shoe until someone steps into it…” – Deloris Jordan., Michael Jordan’s mom. Air: Courting a Legend. Spring 2023. That...
News
With rising real estate costs, it seems impossible for a lot of people to get ahold of some real estate. With limited supply across...
News
Pros Cons What’s new? The sporty and stylish 2024 Kia K5 is a practical midsize sedan with an outstanding warranty and an exciting GT...
News
Introduction Aya Gold & Silver (OTCQX:AYASF) is small silver producer in Morocco. However, they are ramping up production to become a mid-tier producer. Plus,...
News
This is reprinted by permission from . Travelers are flocking away from overcrowded airport terminals and into airport lounges. And so, these lounges have a...
News
Editor’s note: Seeking Alpha is proud to welcome Gems Capital as a new contributor. It’s easy to become a Seeking Alpha contributor and earn...
News
Gold ends July higher; we believe free cash flow generation, not earnings, is a better way to assess the value and investment appeal of...
News
I have previously discussed, in relation to Eli Lilly (LLY), my expectation that the GLP-1 drug class should readily exceed $100 billion in revenues...
